The current wave of cross-border mergers and acquisitions is not a cyclical uptick — it is a structural realignment. Within a single news cycle, the market has witnessed a rejected $56 billion unsolicited takeover, a €128.5-per-share defense sector acquisition in Europe, a billion-dollar SPAC listing in drone logistics, and Merck KGaA’s largest cross-border deal in over a decade. For CFOs, General Counsel, and M&A Directors, the signal is clear: deal velocity is rising, but so is deal complexity.

Rejected Bids and the True Cost of Unsolicited Offers

GameStop’s reported $56 billion unsolicited cash-and-stock approach to eBay — subsequently rejected by the e-commerce platform — illustrates a persistent tension in high-value corporate finance: the gap between strategic ambition and structural readiness. Unsolicited offers of this magnitude require not only a compelling valuation thesis but also a credible post-merger integration roadmap that target boards can evaluate with confidence.

When a target’s board rejects an approach, it is rarely purely about price. Governance concerns, regulatory exposure across multiple jurisdictions, and the acquirer’s demonstrated capacity to execute integration at scale all factor into the decision. For mid-market companies seeking to enter global markets through transformative acquisitions, this case is a pointed reminder that due diligence must run in both directions — assessing not only the target’s financials but also the acquirer’s operational credibility.

Key considerations for boards evaluating unsolicited approaches include:

  • Fiduciary obligations under applicable corporate law (Delaware, UK Companies Act, or EU Takeover Directive equivalents)
  • Antitrust and foreign investment screening requirements, including CFIUS in the US and EU FDI Regulation (2019/452)
  • Reputational and stakeholder management implications of a public rejection

Strategic Acquisitions in Energy, Defense, and Life Sciences: A European Perspective

Three concurrent transactions illustrate where institutional capital is concentrating in 2025. KKR’s acquisition of EDF Power Solutions’ North American assets — valued at approximately $1.2 billion — reflects private equity’s sustained appetite for energy infrastructure with predictable cash flows, particularly as the energy transition creates both stranded-asset risk and new infrastructure demand across the US and Canada.

In European defense, Safran’s entry into exclusive negotiations to acquire sea drone maker Exail Technologies at €128.5 per share signals accelerating consolidation in autonomous maritime systems. This is consistent with broader European defense investment trends following NATO commitments and the EU’s Defence Industrial Strategy, which explicitly targets sovereign capability in unmanned systems. For strategic advisors and General Counsel operating in this sector, the regulatory pathway — including potential review under France’s foreign investment screening regime — warrants early-stage mapping.

Perhaps the most consequential transaction for the life sciences sector is Merck KGaA’s $11.3 billion agreement to acquire US-based Bio-Techne, its largest cross-border deal in over a decade. This acquisition expands Merck’s position in complex drug research and manufacturing tools — a segment experiencing sustained demand driven by biologics and cell and gene therapy pipelines. Cross-border life sciences deals of this scale require careful navigation of both US FDA regulatory considerations and EU pharmaceutical compliance frameworks, in addition to Hart-Scott-Rodino and potential EC merger control review.

SPAC Listings and Venture Capital: Drone Logistics Enters Public Markets

Cargo drone startup Elroy Air’s planned $1 billion Nasdaq listing via SPAC merger with Columbus Circle Capital Corp II represents a maturing of the drone logistics investment thesis. While SPAC structures faced significant regulatory scrutiny from the SEC following the 2021 boom-and-bust cycle, they remain a viable route to public markets for capital-intensive deep-tech ventures where traditional IPO timelines are prohibitive.

For venture capital sponsors and institutional investors, the Elroy Air transaction underscores the importance of robust forward-looking financial disclosures and de-SPAC compliance under SEC Staff Accounting Bulletin guidance. European investors participating in US-listed SPAC transactions should also consider cross-border securities law implications under MiFID II and AIFMD.

Implications for Decision-Makers

The current M&A environment demands a more disciplined, multi-jurisdictional approach to deal structuring. Boards and executive teams should prioritize the following:

  • Early regulatory mapping: FDI screening, antitrust review, and sector-specific approvals must be sequenced into deal timelines from the outset, not retrofitted after signing.
  • Integration architecture before announcement: Post-merger integration planning — including IT systems, compliance frameworks, and talent retention — should be substantively developed prior to public disclosure.
  • Valuation discipline in volatile sectors: Defense and life sciences command premium multiples, but acquirers must stress-test synergy assumptions against regulatory and operational risk.

Key Takeaway

The week’s deal flow confirms that cross-border M&A activity in 2025 is being driven by three converging forces: private equity’s search for infrastructure yield, European strategic consolidation in defense and technology, and life sciences majors repositioning for the next decade of drug development. For corporate finance leaders and their advisors, the differentiating factor will not be access to capital — it will be the quality of due diligence, the credibility of integration planning, and the sophistication of regulatory strategy across multiple jurisdictions simultaneously.